Piramal Enterprises

Piramal sells its DRG business to Clarivate for $950 million

17 Jan 2020

Piramal Enterprises to offer long-term equity in real estate sector

23 Feb 2017

Piramal acquires Mallinckrodt’s pain management drug portfolio for $203 million

30 Jan 2017

Piramal Enterprises to buy five injectable products from Janssen NV

10 Oct 2016

Piramal Enterprises looks to buy OTC business of Morepen Laboratories

23 Sep 2016

Piramal Fund Management invests Rs2,320 cr in Lodha Group’s projects

01 Sep 2016

Piramal, Bain Capital team up to pursue distressed assets in India

25 Aug 2016

Piramal Enterprises to acquire Ash Stevens

16 Aug 2016

Piramal Enterprises to buy four brands from Pfizer for Rs110 cr

14 May 2016

Indoco Remedies acquires Piramal’s clinical research division

02 Apr 2015

Piramal Enterprises raises investment in Shriram group to nearly Rs4,500 cr

05 Jun 2014

Piramal to sell entire stake in Vodafone India for Rs8,900 crore

10 Apr 2014

Ajay Piramal-led Piramal Enterprises Ltd today agreed to sell its 10.97 per cent stake in Vodafone India Ltd to parent Vodafone Group Plc, for Rs8,900 crore

Piramal Enterprises joins hands with Tata Memorial for cancer research

03 Apr 2013

Piramal arm buys market analytics firm Abacus in UK

04 Dec 2012

Piramal to buy US healthcare data firm Decision Resources for Rs3,400 crore

16 May 2012

Piramal Healthcare buys Bayer’s molecular imaging and research portfolio

16 Apr 2012

The acquisition includes Florbetaben, a drug candidate for diagnosis of Alzheimer’s disease that is in the final stages of clinical trials, with potential to generate annual revenues of $1.5 billion

Piramal Healthcare gets EU approval for its regenerative product `BST-CarGel’

11 Apr 2012

Piramal Healthcare to buy additional 5.5% in Vodafone India for Rs3,007 cr

04 Feb 2012

Piramal Healthcare acquires 5.5-% Vodafone Essar stake for $640 million

11 Aug 2011

Drug-maker Piramal Healthcare has picked up a 5.5-per cent equity stake in Vodafone Essar Ltd, the Indian unit of world's second-largest mobile operator

Piramal Healthcare to foray into financial services

06 May 2011

Piramal starts phase-II trials for type-2 diabetes drug

22 Sep 2010

Abbott to keep Piramal business separate after acquisition

11 Sep 2010

Super Religare Labs buys Piramal Diagnostic in Rs600 crore deal

14 Jul 2010

Piramal Healthcare to buy BioSyntech's assets for $3.82 billion

22 Jun 2010

Abbott is India's biggest pharma firm after $3.7-bn Piramal deal

21 May 2010

Abbott plans to fund the transaction with its own cash reserves and says that the acquisition will not impact its ongoing earnings per share guidance in 2010

View details about the software product Informachine News Trackers